Search

everythinglearnresearchcommunity

for

Search:↓

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

Tamoxifen caused hair loss in a 52-year-old woman.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

The method allows for 3D tracking of hair follicle stem cells and shows they can regenerate hair for up to 180 days.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Hair loss is a common side effect of hormone treatments for cancer.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Claudin-1 is crucial for maintaining skin barrier and preventing inflammation.

Removing β-catenin in certain stem cells causes hair whitening and pigmentation issues.

Fatp4 is crucial for healthy skin development and function.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.